The role of myeloid-derived suppressor cells (MDSCs) in cancer development has become clear over recent years, and MDSC targeting is an emerging opportunity for enhancing the effectiveness of current anticancer therapies. As MDSCs are not only able to limit anti-tumour T-cell responses, but also to promote tumour angiogenesis and invasion, their monitoring has prognostic and predictive value. Herein, we review the key features of MDSCs in cancer promotion.
In Brief: Myeloid-derived suppressor cells in cancer
SOLITO, SAMANTHA;PINTON, LAURA;MANDRUZZATO, SUSANNA
2017
Abstract
The role of myeloid-derived suppressor cells (MDSCs) in cancer development has become clear over recent years, and MDSC targeting is an emerging opportunity for enhancing the effectiveness of current anticancer therapies. As MDSCs are not only able to limit anti-tumour T-cell responses, but also to promote tumour angiogenesis and invasion, their monitoring has prognostic and predictive value. Herein, we review the key features of MDSCs in cancer promotion.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PDF In Brief -R-1.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Preprint (submitted version)
Licenza:
Accesso gratuito
Dimensione
367.48 kB
Formato
Adobe PDF
|
367.48 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
